Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells
about
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerIn vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicinAnti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicityColocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells.Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.Polymeric nanomedicine for cancer MR imaging and drug deliveryBeta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy.Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.Recent advances in PEG-PLA block copolymer nanoparticles.Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxiaEsterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.Synthesis, characterization and drug loading property of Monomethoxy-Poly(ethylene glycol)-Poly(ε-caprolactone)-Poly(D,L-lactide) (MPEG-PCLA) copolymers.Fluorescence imaging enabled biodegradable photostable polymeric micelles.Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.Molecular-targeted nanotherapies in cancer: enabling treatment specificity.Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.Protective microencapsulation of β-lapachone using porous glass membrane technique based on experimental optimisation.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.Nanoencapsulation for drug deliveryNanotechnology-enabled delivery of NQO1 bioactivatable drugs.PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells.Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells.Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein.Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm.An amphiphilic nanocarrier based on guar gum-graft-poly(epsilon-caprolactone) for potential drug-delivery applications.Antifungal activity of the naphthoquinone beta-lapachone against disseminated infection with Cryptococcus neoformans var. neoformans in dexamethasone-immunosuppressed Swiss mice.Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery.Phytochemical based nanomedicines against cancer: current status and future prospects.
P2860
Q24614491-860CF00C-F45F-4045-8841-8A07E4764A1CQ28483980-BCA51547-3047-4C7C-A809-8249E2658907Q28606583-2F8531D2-02F3-4B15-BBE4-FEFE548C8C32Q30583249-642FF674-CCEC-460B-88B3-016C2139F1B0Q33437949-8E4E0405-2C9B-4492-8456-B56B62748384Q33629833-4DF33CF5-4406-402F-A074-D8834419751DQ33767952-03E00967-7C49-436C-9CF9-424C826AEC5DQ33773418-57D428BE-6E65-4EC2-9A57-8FC8C1C90589Q33862927-4C9E2A93-C1C0-47A8-A77B-E7EC7F0B07F0Q34047248-698E3A43-DDCD-445B-9B38-158A11F6AF31Q34396707-7995C94C-FC6A-47F7-8508-A06F9A40B452Q35592799-E2608691-9981-48FB-B716-8842152B31DFQ36716649-5B1C98CE-8716-48D1-8250-AAB02C1A98F8Q37291409-D6CDDA0A-0466-4486-8897-82FFE65E1C87Q37351089-970DF98D-F246-43E9-8430-DFAEFB274CA5Q37466552-483A1C23-5890-40AA-AA79-CC234C53880FQ37639772-8C446430-BD1F-4BBA-A4EA-26C428E0A6C4Q37845832-E2359B8F-07B7-4438-A549-6B3AB1A746CDQ37954497-5CD0BC73-C021-41B8-B4C4-BF79467D922FQ38004050-0A33904D-889F-48F8-B5EC-05F52894392EQ38093653-1C6E37D5-8964-4E5C-AC79-5F13D978E43AQ38191981-3DD562A3-5BF8-4C58-83EB-042B107C7884Q38400036-3B507329-A306-46A9-B86C-655670BA1DF2Q38588547-E972F891-6F06-4753-802B-D7A83234795DQ38594967-02A69019-31D3-4305-9DE9-1EE0C31A72CBQ38603364-4A298AB7-27B4-403A-9205-32020685B914Q38677767-30DB7349-7DE6-4456-839C-38C85AE62DB0Q38759487-26E96CC6-8245-40CB-915A-D84717A7CE5CQ39099843-38349724-1A6A-4114-8765-CEF7FA535B51Q39177694-E75257AF-0734-4142-8367-58F26E69D6E8Q39633123-A77D8E4E-5947-47EA-9E34-E498BE8D9D44Q39816199-0D78E4CE-1530-46AC-B2FF-4595EC164BEAQ42150334-F25B9447-3FB8-43D1-882D-80E5A862228FQ43059954-08073F9F-AF24-43A9-B250-8D3296502957Q43140020-91989A02-73F1-47BE-8C5A-587D4C69D895Q46086889-D110DA3B-FC3D-425F-930A-FEACA67AF307Q47829215-DED3BD8B-C5CB-4B28-9650-B72B8BFB955A
P2860
Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@ast
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@en
type
label
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@ast
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@en
prefLabel
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@ast
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@en
P2093
P2860
P1476
Beta-lapachone-containing PEG- ...... QO1-overexpressing tumor cells
@en
P2093
Damon M Sutton
David A Boothman
Erik A Bey
Jinming Gao
P2860
P304
P356
10.1016/J.JCONREL.2007.04.014
P407
P577
2007-04-29T00:00:00Z